Polyreactive antibodies in adaptive immune responses to viruses (Q37951868)

25 August 2017

Polyreactive antibodies in adaptive immune responses to viruses (English)

1 reference

25 August 2017

1 reference

Michel C. Nussenzweig

series ordinal

2

object named as

Michel C Nussenzweig

1 reference

25 August 2017

1

Hugo Mouquet

1 reference

25 August 2017

2 November 2011

1 reference

Cellular and Molecular Life Sciences

25 August 2017

1 reference

25 August 2017

69

1 reference

25 August 2017

1435-1445

1 reference

25 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-011-0872-6

25 August 2017

0 references

cites work

Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Polyreactivity of antibody molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Evolving concepts of specificity in immune reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

The strange cross-reaction of menadione (vitamin K3) and 2,4-dinitrophenyl ligands with a myeloma protein and some conventional antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

The specificity of cross‐reactivity: Promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Exquisite specificity and peptide epitope recognition promiscuity, properties shared by antibodies from sharks to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Molecular structure of eight human autoreactive monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Predominant autoantibody production by early human B cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Structural insights into the evolution of an antibody combining site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Flexibility and molecular recognition in the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Role of Antibody Paratope Conformational Flexibility in the Manifestation of Molecular Mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Conformational isomerism and the diversity of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Multiple paths to multispecificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Somatic generation of antibody diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Variability in the Lambda Light Chain Sequences of Mouse Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Cellular and genetic mechanisms of self tolerance and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

A checkpoint for autoreactivity in human IgM+ memory B cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Persistent expression of autoantibodies in SLE patients in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Defective B cell tolerance checkpoints in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Impaired early B cell tolerance in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Bruton's tyrosine kinase is essential for human B cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Autoreactivity in human IgG+ memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Mature B cells class switched to IgD are autoreactive in healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Natural polyreactive immunoglobulin A antibodies produced in mouse Peyer's patches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Somatic mutations can lead to a loss of superantigenic and polyreactive binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

The evolution of human anti-double-stranded DNA autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

B-cell tolerance checkpoints in health and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

B-cell self-tolerance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Autoantibody to “intermediate filaments” in infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Anti-intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Characterization of human smooth muscle autoantibodies reacting with cytoplasmic intermediate filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Molecular characterization of virus-induced autoantibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Antiviral immune responses: triggers of or triggered by autoimmunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

EBV in MS: guilty by association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Nonrandom association of cellular antigens with HTLV-III virions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Association of human immunodeficiency virus infection and autoimmune phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

The antigenic structure of the HIV gp120 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Natural human antibodies retrieved by phage display libraries from healthy donors: polyreactivity and recognition of human immunodeficiency virus type 1gp120 epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Cross-clade HIV-1 neutralization by an antibody fragment from a lupus phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Targeting human immunodeficiency virus type 1 with antibodies derived from patients with connective tissue disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Is autoimmunity a component of natural immunity to HIV?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Antibody neutralization and escape by HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Challenges for structure-based HIV vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Distribution and three-dimensional structure of AIDS virus envelope spikes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Membrane association and epitope recognition by HIV-1 neutralizing anti-gp41 2F5 and 4E10 antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Role of HIV membrane in neutralization by two broadly neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Broad neutralization coverage of HIV by multiple highly potent antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Cross-reacting antibodies enhance dengue virus infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0872-6

Increased utilization of polyreactive B cells during periods of generalized immune activation

21 January 2018

1 reference

12 December 2020

Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk

1 reference

12 December 2020

Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding

1 reference

12 December 2020

Autoimmune reactivity in sheep induced by the visna retrovirus

1 reference

12 December 2020

Liver autoreactivity in acute virus A, B and non-A, non-B hepatitis.

1 reference

12 December 2020

Thirty-six human monoclonal immunoglobulins with antibody activity against cytoskeleton proteins, thyroglobulin, and native DNA: immunologic studies and clinical correlations

1 reference

12 December 2020

Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis.

1 reference

12 December 2020

Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset

1 reference

12 December 2020

Human monoclonal rheumatoid factor-like antibodies from CD5 (Leu-1)+ B cells are polyreactive

1 reference

12 December 2020

Maturation of an antibody response is governed by modulations in flexibility of the antigen-combining site

1 reference

12 December 2020

Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis

1 reference

12 December 2020

Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire

1 reference

12 December 2020

Structural patterns in anti-DNA antibodies from MRL/lpr mice

1 reference

12 December 2020

Naturally occurring antibodies against nine common antigens in humans sera. II. High incidence of monoclonal Ig exhibiting antibody activity against actin and tubulin and sharing antibody specificities with natural antibodies

1 reference

12 December 2020

From natural polyreactive autoantibodies to à la carte monoreactive antibodies to infectious agents: is it a small world after all?

1 reference

12 December 2020

Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments

1 reference

12 December 2020

The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans

1 reference

12 December 2020

Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response

1 reference

12 December 2020

Residues that mediate DNA binding of autoimmune antibodies

1 reference

12 December 2020

Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems

1 reference

12 December 2020

Characterization of human CD5 (Leu-1, OKT1)+ B lymphocytes and the antibodies they produce

1 reference

12 December 2020

In vivo polyclonal B-lymphocyte activation elicited by murine viruses

1 reference

12 December 2020

Polyreactive IgM antibodies in the circulation are masked by antigen binding

1 reference

12 December 2020

Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans

1 reference

12 December 2020

Antigen-binding B cells and polyreactive antibodies

1 reference

12 December 2020

Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes

1 reference

12 December 2020

Experimental approaches to homogenous antibody populations. Myeloma proteins with antihapten antibody activity

1 reference

12 December 2020

Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting

1 reference

12 December 2020

Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections

1 reference

12 December 2020

Paratope plasticity in diverse modes facilitates molecular mimicry in antibody response

1 reference

12 December 2020

Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with clade A and B viruses

1 reference

12 December 2020

Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus

1 reference

12 December 2020

Antibody polyspecificity and neutralization of HIV-1: a hypothesis

1 reference

12 December 2020

Few and far between: how HIV may be evading antibody avidity

1 reference

12 December 2020

Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells

1 reference

12 December 2020

Control of early viral and bacterial distribution and disease by natural antibodies

1 reference

12 December 2020

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

1 reference

12 December 2020

Determinants of polyreactivity in a large panel of recombinant human antibodies from HIV-1 infection.

1 reference

12 December 2020

Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization

1 reference

12 December 2020

Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens

1 reference

12 December 2020

Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin.

1 reference

12 December 2020

Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated

1 reference

12 December 2020

Characterization of murine polyreactive antigen-binding B cells: presentation of antigens to T cells

1 reference

12 December 2020

Acquired immune deficiency syndrome (AIDS) and autoimmunity--mutually exclusive entities?

1 reference

12 December 2020

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

1 reference

12 December 2020

10.1007/S00018-011-0872-6

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22045557